Recent internal discussions among the Public Health Agency of Canada (PHAC) revealed significant concerns regarding the reliability of data on COVID-19 vaccine injuries and the decision to stop publicly reporting this information. Senior officials expressed a reluctance to label vaccines as "safe," reflecting the complexities surrounding vaccine safety data.
1. Discontinuation of Public Updates:
● PHAC's management decided to halt public updates on reported COVID-19 vaccine injuries, prioritizing the resolution of data tracking issues instead.
● Internal communications highlighted discrepancies in data and significant backlogs, which questioned the reliability of the data used for public reporting.
2. Public Claims and Underestimation:
● An investigation showed that PHAC greatly underestimated the number of Canadians reporting vaccine injuries, expecting only 40 claims per year but receiving around 400.
● As of late 2023, there were 3,317 claims filed with 1,738 still pending.
3. Critique of Tracking Systems:
● PHAC’s vaccine tracking faced issues due to reliance on provincial registries that lacked critical co-administration data.
● Conflict in definitions of "serious" adverse events between PHAC and Health Canada complicated the tracking further and skewed statistics.
4. International Context:
● Canada's issues mirrored challenges faced by the U. S. FDA, which allegedly used flawed methodologies to track adverse vaccine events, according to Wisconsin GOP Senator Ron Johnson.
5. Public Messaging Strategy:
● Officials debated how to communicate the discontinuation of reporting. Concerns were raised that the public might interpret the pause as evidence of a hidden agenda.
● Executive Director Susanna Ogunnaike-Cooke indicated that the vaccines could not be labeled "safe" due to documented adverse events. Instead, the message shifted to one of "extensive evidence on COVID-19 vaccine safety has been gathered. "
6. Shift in Reporting Approach:
● Reports transitioned from frequent updates to a new webpage integrating all vaccines into routine reporting. This included adjustments to how serious adverse events were communicated to maintain public confidence in vaccinations.
Internal discussions at PHAC about the COVID-19 vaccine safety reporting have revealed substantial inconsistencies in data management and public messaging. The decision to stop regular updates drew criticism due to the potential for public mistrust. Future communications will emphasize the vast evidence collected but will not categorically assert the vaccines as "safe," reflecting the nuanced challenges in public health messaging amidst evolving vaccine data and perceptions.
No comments:
Post a Comment